1. Introduction {#j_med-2019-0006_s_001}
===============

Alzheimer's disease (AD) is among the most frequently found forms of neurodegenerative dementia in mature persons, constituting a crucial public health concern worldwide \[[@j_med-2019-0006_ref_001], [@j_med-2019-0006_ref_002]\]. In addition, 47.3 million people globally were suffering from AD in 2015, and the number of AD patients is expected to grow to 133 million by 2050, according to the International Alzheimer's Disease Report \[[@j_med-2019-0006_ref_003], [@j_med-2019-0006_ref_004]\]. Furthermore, clinical characteristics of AD include memory impairment, in addition to behavioral as well as cognitive deficiencies \[[@j_med-2019-0006_ref_005]\]. AD comprises early-onset AD (EOAD) and late-onset AD (LOAD). LOAD, accounting for the most AD, is presumed to be a consequence of both ecological and genetic factors \[[@j_med-2019-0006_ref_003], [@j_med-2019-0006_ref_005]\].

The development of AD is assumed to result from an intricate relationship among several genetic, ecological and lifestyle factors \[[@j_med-2019-0006_ref_006]\]. There is increasing evidence suggesting that genetic factors substantially contribute toward the AD etiology through contact with the ecological components \[[@j_med-2019-0006_ref_007], [@j_med-2019-0006_ref_008]\]. In addition, the strongest known genetic risk factor with regard to LOAD is the ɛ4 allele of the apolipoprotein E (APOE ɛ4) gene \[[@j_med-2019-0006_ref_009], [@j_med-2019-0006_ref_010], [@j_med-2019-0006_ref_011]\]. Numerous investigations have reported several genetic variants, to be linked to LOAD along with the APOE genotype, including the ABCA7, EPHA1, CD33, MS4A6A, and MTHFR gene \[[@j_med-2019-0006_ref_012], [@j_med-2019-0006_ref_013], [@j_med-2019-0006_ref_014]\].

Methylene-tetrahydrofolate reductase (MTHFR) constitutes the primary enzyme of the folate metabolism pathway, impacting not only DNA synthesis, but also methylation as well as the repair mechanism \[[@j_med-2019-0006_ref_015]\]. It catalyzes the conversion of 5,10-methylenetetrahydrofolate to 5-methyltetrahydrofolate, in addition to being the methyl donor for the remethylation of homocysteine to methionine \[[@j_med-2019-0006_ref_016]\]. Numerous single nucleotide polymorphisms have been discovered in the MTHFR gene; among them, the C677T polymorphism is the most investigated as well as the most significant clinically. Lowered MTHFR activity gives rise to the dietary requirement for folic acid that is needed for the purpose of maintaining the normal homocysteine (Hcy) remethylation to methionine. Furthermore, folate deficiency, together with the consequent augmented levels of plasma homocysteine is associated with the poor cognitive performance, in addition to being linked to AD \[[@j_med-2019-0006_ref_017], [@j_med-2019-0006_ref_018]\].

Previous research has been carried out on the underlying link between MTHFR C677T polymorphism and the susceptibility to LOAD; nevertheless, conclusions of these studies are inconsistent.. Accordingly, we carried out the present meta-analysis of published investigations aimed at obtaining a more dependable conclusion of this link.

2. Methods and materials {#j_med-2019-0006_s_002}
========================

2.1. Selection of literatures {#j_med-2019-0006_s_002_s_001}
-----------------------------

Each of the possible studies was chosen through a search the databases of PubMed, EMBASE, Cochrane Library, and WanFang databases (the last search was updated on August 10, 2018), with the use of keywords as well as the subject terms "polymorphism\*" or "variant\*" or "mutation\*", "methylenetetrahydrofolate reductase" or "MTHFR", and "Alzheimer's disease". There was no language limitation.

2.2. Inclusion and exclusion criteria {#j_med-2019-0006_s_002_s_002}
-------------------------------------

We selected those research works that met the following criteria; (i) the study evaluates the association between the C677T polymorphism of the MTHFR gene and the susceptibility to LOAD; (ii) the study provides sufficient data for the calculation of the odds ratios (ORs) with its respective 95% CI); (iii) exact diagnosis of LOAD was performed with the application of the generally accepted criteria; (iv) the study must be designed as a case-control and based on humans. The major exclusion criteria were as follows: (i) only a case study design; (ii) lacking available genotype frequency; (iii) an abstract of a meeting. In addition, the paper was commented upon and reviewed. When several studies reported the same data category, the largest or the most recent publication was selected.

2.3. Data extraction {#j_med-2019-0006_s_002_s_003}
--------------------

Careful extraction of the data of competent research works was performed independently by two authors according to the inclusion criteria presented above. Furthermore, the data hereunder were recorded: (i) name of the first author, in addition to the date of publication, country as well as ethnicity of origin; (ii) genotyping methods, in addition to genotype distributions in both the cases and controls; criteria for LOAD diagnosis; and Hardy-Weinberg equilibrium (HWE) in controls. Resolution of disparities was performed with the assistance of discussion between authors.

2.4. Statistical analysis {#j_med-2019-0006_s_002_s_004}
-------------------------

All analyses were carried out using STATA 15.0 (Stata Corp, College Station, TX, USA). To evaluate the link of MTHFR C677T with the vulnerability to LOAD, the significance of the pooled odds ratios (ORs) was calculated by a Z-test. We also carried out a subgroup analysis based on ethnicity as well as APOE ɛ4 status. We accessed heterogeneity among included research works using a chi-square--based Q test, coupled with an I2 statistic. The fixed-effects model was put to use when the *Q*-test led to *P*-value \> 0.1 or the *I*^2^ test of *I*^2^\<50% \[[@j_med-2019-0006_ref_019]\]; alternatively, the random-effects model was adopted \[[@j_med-2019-0006_ref_020]\]. To evaluate the constancy of findings, we carried out a sensitivity analysis through the omission of a single investigation every time. Examination of the latent publication partiality was performed using Begg's funnel plots as well as Egger's test \[[@j_med-2019-0006_ref_021], [@j_med-2019-0006_ref_022]\]; and a P-value less than 0.05 suggested a substantial publication partiality.

3. Results {#j_med-2019-0006_s_003}
==========

3.1. Study characteristics {#j_med-2019-0006_s_003_s_001}
--------------------------

As evident from [Figure 1](#j_med-2019-0006_fig_001){ref-type="fig"}, an aggregate of 343 articles was recognized in the preliminary search in PubMed, EMBASE, the Cochrane Library, as well as WanFang databases. Subsequent to the deduplication and exclusion of the clearly irrelevant studies, an aggregate of 14 case-control research works was retrieved, which involved 2,467 LOAD patients with 2,877 controls \[[@j_med-2019-0006_ref_014], [@j_med-2019-0006_ref_023], [@j_med-2019-0006_ref_024], [@j_med-2019-0006_ref_025], [@j_med-2019-0006_ref_026], [@j_med-2019-0006_ref_027], [@j_med-2019-0006_ref_028], [@j_med-2019-0006_ref_029], [@j_med-2019-0006_ref_030], [@j_med-2019-0006_ref_031], [@j_med-2019-0006_ref_032], [@j_med-2019-0006_ref_033], [@j_med-2019-0006_ref_034], [@j_med-2019-0006_ref_035]\]. Key attributes of individual investigations are summarized in [Table 1](#j_med-2019-0006_tab_001){ref-type="table"}.

![Flow diagram of publication selection process.](med-14-032-g001){#j_med-2019-0006_fig_001}

###### 

Main characteristics of studies selected in the meta-analysis

  Author       Year   Country   Ethnicity   Diagnosis criteria       Case   Control   Genotyping methods   HWE
  ------------ ------ --------- ----------- ------------------------ ------ --------- -------------------- -------
  Belcavello   2014   Brazil    Mixed       NR                       82     161       PCR-RFLP             0.171
  Bi           2009   China     Asian       NINCDS--ADRDA/DSM-IV     386    375       PCR-RFLP             0.125
  Coppede      2012   Italy     Caucasian   NINCDS--ADRDA/DSM-IV     378    305       PCR--RFLP            0.44
  Elhawary     2013   Egypt     Mixed       NINCDS--ADRDA            32     32        PCR                  0.628
  Giedraitis   2009   Sweden    Caucasian   NINCDS-ADRDA/DSM-IV      85     375       IGA                  0.125
  Keikhaee     2006   Iran      Asian       NINCDS--ADRDA            117    125       PCR-RFLP             0.07
  Kida         2004   Japan     Asian       NINCDS--ADRDA            194    379       PCR-RFLP             0.056
  Pollak       2000   Israel    Caucasian   NINCDS--ADRDA            92     82        PCR                  0.501
  Prince       2001   Sweden    Caucasian   NINCDS--ADRDA            204    172       DASH                 0.232
  Ravaglia     2004   Italy     Caucasian   NINCDS-ADRDA/-AIREN      48     122       PCR                  0.412
  Seripa       2003   USA       Caucasian   NINCDS-ADRDA             124    97        PCR-SSCP             0.781
  Stoccoro     2017   Italy     Caucasian   NINCDS-ADRDA/DSM-IV      581    468       PCR-RFLP             0.139
  Wang         2005   China     Asian       NINCDS-ADRDA/DSM-III-R   104    130       PCR                  0.339
  Zuliani      2001   Italy     Caucasian   NINCDS-ADRDA             40     54        PCR                  0.627

Abbreviations: NR, not reported; ; NINCDS-ADRDA, National Institute of Neurological and Communicative Disorders and Stroke-Alzheimer's Disease and Related Disorders Association Criteria; DSM-IV, Diagnostic and Statistical Manual of Mental Disorders (Fourth Edition); DSM-III-R, Diagnostic and Statistical Manual of Mental Disorders, Third Edition, Revised; HWE, Hardy-Weinberg equilibrium in control population; PCR--RFLP, polymerase chain reaction-restriction fragment length polymorphism; PCR--SSCP, polymerase chain reaction-single strand conformation polymorphism; DASH, dynamic allele-specific hybridization; IGA, Illumina GoldenGate Assay.

3.2. MTHFR C677T polymorphism with the susceptibility to LOAD {#j_med-2019-0006_s_003_s_002}
-------------------------------------------------------------

In the current meta-analysis, we evaluated the association of MTHFR C677T polymorphism with the vulnerability to LOAD through five genetic model comparisons. The results indicated that the MTHFR C677T polymorphism was substantially associated with the LOAD risk in the co-dominant framework (TC vs. CC: OR=1.22, 95%CI=1.00-1.49, P=0.049, [Figure 2](#j_med-2019-0006_fig_002){ref-type="fig"}) in populations in general. Performing the stratified analysis based on ethnicity, a substantially augmented threat of LOAD was observed in Asian populations subjected to the allelic (T vs. C: OR=1.43, 95%CI=1.09-1.87, P=0.009, [Figure 3](#j_med-2019-0006_fig_003){ref-type="fig"}), in addition to recessive (TT vs. CC+TC: OR=1.82, 95%CI=1.05-3.15, P=0.032), dominant (TT+TC vs. CC: OR=1.43, 95%CI=1.10-1.85, P=0.007),

![Meta-analysis for the association between MTHFR C677T polymorphism and LOAD susceptibility under the co-dominant model.](med-14-032-g002){#j_med-2019-0006_fig_002}
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and co-dominant (TC vs. CC: OR=1.26, 95%CI=1.01-1.57, P=0.037; TT vs. CC: OR=2.09, 95%CI=1.16-3.77, P=0.014) models. The current meta-analysis showed an extensive between-study heterogeneity; therefore, the random-effect model was carried out to evaluate the association between MTHFR C677T polymorphism and the vulnerability to LOAD. Additionally, stratified analysis by APOE ɛ4 status suggested that a substantial rise in the susceptibility to LOAD was found in APOE ɛ4 carriers under the allelic (T vs. C: OR=1.47, 95%CI=1.14-1.91, P=0.003, [Figure 4](#j_med-2019-0006_fig_004){ref-type="fig"}), together with dominant (TT+TC vs. CC: OR=1.67, 95%CI=1.16-2.42, P=0.006), and co-dominant (TC vs. CC: OR=1.54, 95%CI=1.04-2.28, P=0.030; TT vs. CC: OR=1.97, 95%CI=1.15-3.37, P=0.013) models. Additionally, similar results were found in non-APOE ɛ4 carriers. The fixed-effects framework was selected because there existed no substantial heterogeneity among between-study, per the main results in [Table 2](#j_med-2019-0006_tab_002){ref-type="table"}.

###### 

Meta-analysis of the MTHFR C677T polymorphism and late-onset Alzheimer's disease susceptibility

  Comparison   Subgroup                      Studies   Test of heterogeneity   Test of association   Model             Publication bias       
  ------------ ----------------------------- --------- ----------------------- --------------------- ----------------- ------------------ --- -------
  T vs. C      Overall                       14        \<0.001                 80.6                  1.16(0.95-1.41)   0.147              R   0.839
               Asian                         4         0.022                   68.8                  1.43(1.09-1.87)   0.009              R   \-
               Caucasian                     8         \<0.001                 80.9                  1.09(0.89-1.34)   0.648              R   \-
               APOE ɛ4 carrier non-APOE ɛ4   4         0.309                   16.5                  1.47(1.14-1.91)   0.003              F   \-
               carrier Overall               4         0.241                   28.5                  1.31(1.12-1.54)   0.001              F   \-
  TC vs. CC    Asian                         14        0.009                   53.8                  1.22(1.00-1.49)   0.049              R   0.862
               Caucasian                     4         0.403                   0                     1.26(1.01-1.57)   0.037              R   \-
               APOE ɛ4 carrier non-APOE ɛ4   8         0.016                   59.4                  1.05(0.80-1.39)   0.706              R   \-
               carrier Overall               4         0.212                   33.4                  1.54(1.04-2.28)   0.030              F   \-
               Asian                         4         0.922                   0                     1.22(0.94-1.59)   0.132              F   \-
  TT vs. CC    Caucasian                     14        \<0.001                 75.4                  1.23(0.84-1.81)   0.286              R   0.915
               APOE ɛ4 carrier non-APOE ɛ4   4         0.027                   67.2                  2.09(1.16-3.77)   0.014              R   \-
               carrier Overall               8         \<0.001                 78.7                  0.84(0.49-1.42)   0.507              R   \-
               Asian                         4         0.607                   0                     1.97(1.15-3.37)   0.013              F   \-
               Caucasian                     4         0.094                   53.0                  2.06(1.23-3.47)   0.006              R   \-
  TC+TT vs     APOE ɛ4 carrier non-APOE ɛ4   14        \<0.001                 73.1                  1.24(0.97-1.58)   0.090              R   0.878
  CC           carrier Overall               4         0.208                   34.1                  1.43(1.10-1.85)   0.007              R   \-
               Asian                         8         \<0.001                 77.6                  0.98(0.69-1.39)   0.912              R   \-
               Caucasian                     4         0.347                   9.3                   1.67(1.16-2.42)   0.006              F   \-
               APOE ɛ4 carrier non-APOE ɛ4   4         0.973                   0                     1.38(1.08-1.77)   0.011              F   \-
  TT vs        carrier                       14        \<0.001                 68.3                  1.11(0.82-1.51)   0.496              R   0.954
  TC+CC                                      4         0.022                   68.9                  1.82(1.05-3.15)   0.032              R   \-
                                             8         0.002                   69.9                  0.84(0.56-1.26)   0.409              R   \-
                                             4         0.262                   25.0                  1.58(0.98-2.56)   0.061              F   \-
                                             4         0.011                   73.0                  1.83(1.02-3.30)   0.044              R   \-

Abbreviations: APOE, Apolipoprotein E; OR, odds ratio; CI, confidence interval; F, fixed-effects model; R, random-effects model; NA, not available.

3.3. Sensitivity analysis and publication bias {#j_med-2019-0006_s_003_s_003}
----------------------------------------------

We performed a sensitivity analysis to assess the impact of the individual investigations, addressing the pooled OR by sequentially removing each eligible study. The evidence revealed the robustness and reliability of our results ([Figure 5](#j_med-2019-0006_fig_005){ref-type="fig"}). Moreover, funnel plots and Egger's test were performed to assess the latent publication partiality, and demonstrated that there was no obvious publication partiality ([Table 2](#j_med-2019-0006_tab_002){ref-type="table"}).
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4. Discussion {#j_med-2019-0006_s_004}
=============

Alzheimer's disease (AD) is a complex neurodegenerative dementia in aging persons. Memory impairment constitutes a typical clinical feature of AD. The pathogenesis of AD is regarded as the consequence of contact between ecological and genetic elements. The ɛ4 allele of Apolipoprotein E (*APOE ɛ*4) gene is hitherto the most robust known genetic risk in patients who have late-onset Alzheimer's disease (LOAD). Identification of the genetic variants in addition to *APOE* genotype that contributed to the development of LOAD has the potential to reveal some effective interventions that could lower the incidence of the disease.

Several experimental and epidemiological study results have connected disorders of folate metabolism of homocysteine to vascular, neurodegenerative, neuropsychiatric, and neoplastic disease, including not only strokes, but also Parkinson's disease, Alzheimer disease, and glioma \[[@j_med-2019-0006_ref_014], [@j_med-2019-0006_ref_036], [@j_med-2019-0006_ref_037], [@j_med-2019-0006_ref_038], [@j_med-2019-0006_ref_039], [@j_med-2019-0006_ref_040]\]. Moreover, methylenetetrahydrofolate reductase (MTHFR) is an important enzyme for in the folate metabolism of homocysteine. The human MTHFR gene is localized in the chromosome locus; the

protein it produces catalyzes the conversion of 5,10-methylenetetrahydrofolate to 5-methyltetrahydrofolate, the methyl donor for the remethylation of homocysteine to methionine \[[@j_med-2019-0006_ref_016], [@j_med-2019-0006_ref_040]\]. Mutation in the MTHFR gene could result to reducing its methylene tetrahydrofolate reductase activity, putting homocysteine transferring to methionine in malfunctioning, thus giving rise to a higher plasma homocysteine concentration. Additionally, an augmented level of homocysteine and a lack of folate occur, increasing the risk of impairment to oligodendrocytes because of not only the amyloid precursor protein but also presenilin-1 \[[@j_med-2019-0006_ref_040]\]. Numerous single nucleotide polymorphisms in the MTHFR gene have been identified, whereof C677T polymorphism is the most studied and is the clinically important \[[@j_med-2019-0006_ref_041]\]. Nevertheless, the involvement of the MTHFR C677T with the vulnerability to LOAD is not consensual.

Since April 1998, associated research works addressing the link between the MTHFR genetic variants and the susceptibility to AD have been performed in study groups of differing ethnicities. Chapman et al. reported case-control investigations that suggested that MTHFR C677T polymorphism was not substantially linked to the susceptibility to Alzheimer's dementia \[[@j_med-2019-0006_ref_042]\]. Concerning the risk for LOAD, the MTHFR C677T polymorphism had a slight link to the onset of senile dementia in men but not with LOAD by Nishiyama et al \[[@j_med-2019-0006_ref_043]\]. Stoccoro et al.'s study showed that the MTHFR C677T polymorphism constituted a risk factor for LOAD in non-Asian populations, either in *APOE ɛ* ɛ4 or in non-APOE ɛ4 carriers \[[@j_med-2019-0006_ref_014]\]. In the year 2010, a meta-analysis conducted by Zhang et al. demonstrated that the polymorphism of MTHFR C677T was substantially linked to the vulnerability to LOAD in the allelic and dominant model comparisons in East Asian populations \[[@j_med-2019-0006_ref_044]\]. Peng et al. performed a meta-analysis, which suggested that the MTHFR C677T polymorphism was linked to the augmented susceptibility to LOAD in Asians and *APOE ɛ*4 carriers, not in non-*APOE ɛ*4 carriers, early-onset Alzheimer's disease (EOAD) as well as in Caucasians \[[@j_med-2019-0006_ref_045]\]. The present meta-analysis is the first comprehensive systematic evaluation of the potential link between the MTHFR C677T polymorphism and the vulnerability to LOAD: the polymorphism of MTHFR C677T was linked to an increased susceptibility to LOAD in the co-dominant model. Moreover, by means of the stratification analysis in accordance with ethnicity, a substantially augmented risk of LOAD was observed in Asians. IMportantly, we carried out the stratified analysis based on APOE ɛ4 status, wherein we have found a significant increase in the susceptibility to LOAD in *APOE ɛ*4 as well as in non-*APOE ɛ*4 carriers.

Interpreting findings through the meta-analysis, some constraints require mention. Firstly, the included research works were constrained to literature in English and Chinese only, which is likely to introduce a limitation for interpreting the findings. Secondly, substantially between-study heterogeneity was also discovered, which is likely to distort the meta-analysis. Thirdly, specimen size in some of the involved investigations was comparatively smaller for investigating the link existing between MTHFR C677T polymorphism and AD risk. Finally, lack of the genuine data for competent research works studies, we were not able to estimate the susceptibility to LOAD stratified analysis based on sex, life-style, and other risk factors.

5. Conclusion {#j_med-2019-0006_s_005}
=============

The present meta-analysis revealed that the polymorphism of MTHFR C677T might contribute to individual susceptibility to LOAD in Asian populations, *APOE ɛ*4, and non-*APOE ɛ*4 carriers. Further research involving a large-scale, multi-center sample is required for the purpose of clarifying our findings.
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